{
    "pmcid": "10975102",
    "qa_pairs": {
        "What expression system and host were used for the production of the LTp50 protein?": [
            "E. coli Rosetta strain",
            "Saccharomyces cerevisiae",
            "Pichia pastoris",
            "Bacillus subtilis"
        ],
        "What purification technique was used for the LTp50 protein?": [
            "Immobilized metal affinity chromatography (IMAC)",
            "Size-exclusion chromatography",
            "Ion-exchange chromatography",
            "Reverse-phase chromatography"
        ],
        "What was the outcome of the immunogenicity assessment of the LTp50 vaccine in BALB/c mice?": [
            "It elicited significant IgG responses but did not induce neutralizing antibodies in a pseudovirus assay",
            "It induced strong neutralizing antibodies in a pseudovirus assay",
            "It failed to elicit any IgG response",
            "It caused severe adverse reactions in the mice"
        ],
        "What was the rationale behind the selection of epitopes for the LTp50 vaccine?": [
            "Their ability to induce neutralizing antibodies and conservation across variants",
            "Their high mutation rate and variability",
            "Their exclusive presence in the BA.5 variant",
            "Their ability to bind to non-spike proteins"
        ],
        "Which tool was used to model the structure of the LTp50 protein?": [
            "AlphaFold Colab",
            "RosettaDock",
            "MODELLER",
            "PyMOL"
        ]
    }
}